Rare Cancers Australia (RCA) has welcomed the release of the highly anticipated Senate report into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancers.
Read more arrow_forwardRare Cancers Australia (RCA) welcomed the Federal Government’s budget announcement this week,…
Read more arrow_forwardPeak cancer body, Rare Cancers Australia, has co-authored a pre-Budget submission of…
Read more arrow_forward
The peak body for rare cancers in Australia welcomes two new members…
Read more arrow_forwardOver the past two decades, our ability to rapidly obtain genomic information on an individual and their cancer has led to a dramatic shift in how we can diagnose, treat, monitor and prevent cancer, leading to an era of precision oncology.
Read more arrow_forwardRare Cancers Australia, and an army of peak cancer organisations, call on the Pharmaceutical Benefits Advisory Committee (PBAC) to expand access to the breakthrough PD-1/PD-L1 inhibitor class of medicines for the more than 3,500 Aussies who would benefit.
Read more arrow_forwardOver 650 people will be descending on Thredbo this week (15th & 16th March) to take on Australia’s highest peak, Mount Kosciuszko, in a charity challenge to raise awareness and vital funds for rare and less common cancers.
Read more arrow_forwardRare Cancers Australia has welcomed a recent approval by the TGA of the Novartis targeted therapy drug Tafinlar + Mekinist, which has proven to be effective in treating an extremely rare form of cancer mutation called BRAF 600E.
Read more arrow_forwardPioneering national genomics initiative gives 23,000 Australians their best fighting chance against the toughest cancers.
Read more arrow_forward
Rare Cancers Australia (RCA) has launched the country’s first comprehensive support guide dedicated to the unique challenges of a rare cancer experience.
Read more arrow_forward